XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 3,500,000 $ 1,240 $ 31,864,479 $ (30,353,768) $ 5,011,951
Beginning balance, shares at Dec. 31, 2020 350,000 12,402,157      
Proceeds from sale of common stock in direct equity offering, net of offering costs $ 113 3,689,648 3,689,761
Proceeds from sale of common stock in direct equity offering, net of offering costs, shares   1,133,102      
Stock-based compensation expense 1,506,836 1,506,836
Net loss for the period (3,460,310) (3,460,310)
Exercise of warrants $ 1 17,099 17,100
Exercise of warrants, shares   3,000      
Exercise of stock options $ 12 100,988 101,000
Exercise of stock options, shares   125,001      
Ending balance, value at Jun. 30, 2021 $ 3,500,000 $ 1,366 37,179,050 (33,814,078) 6,866,338
Ending balance, shares at Jun. 30, 2021 350,000 13,663,260      
Beginning balance, value at Mar. 31, 2021 $ 3,500,000 $ 1,354 36,227,258 (32,080,912) 7,647,700
Beginning balance, shares at Mar. 31, 2021 350,000 13,538,259      
Stock-based compensation expense 850,804 850,804
Net loss for the period (1,733,166) (1,733,166)
Exercise of warrants $ 12 100,988 101,000
Exercise of warrants, shares   125,001      
Ending balance, value at Jun. 30, 2021 $ 3,500,000 $ 1,366 37,179,050 (33,814,078) 6,866,338
Ending balance, shares at Jun. 30, 2021 350,000 13,663,260      
Beginning balance, value at Dec. 31, 2021 $ 3,500,000 $ 1,374 38,371,128 (37,082,164) 4,790,338
Beginning balance, shares at Dec. 31, 2021 350,000 13,746,593      
Proceeds from sale of common stock in direct equity offering, net of offering costs $ 290 5,141,094 5,141,384
Proceeds from sale of common stock in direct equity offering, net of offering costs, shares   2,900,000      
Stock-based compensation expense 763,766 763,766
Net loss for the period (3,203,222) $ (3,203,222)
Exercise of stock options, shares        
Ending balance, value at Jun. 30, 2022 $ 3,500,000 $ 1,664 44,275,988 (40,285,386) $ 7,492,266
Ending balance, shares at Jun. 30, 2022 350,000 16,646,593      
Beginning balance, value at Mar. 31, 2022 $ 3,500,000 $ 1,374 38,710,800 (38,739,082) 3,473,092
Beginning balance, shares at Mar. 31, 2022 350,000 13,746,593      
Proceeds from sale of common stock in direct equity offering, net of offering costs $ 290 5,141,094 5,141,384
Proceeds from sale of common stock in direct equity offering, net of offering costs, shares   2,900,000      
Stock-based compensation expense 424,094 424,094
Net loss for the period (1,546,304) (1,546,304)
Ending balance, value at Jun. 30, 2022 $ 3,500,000 $ 1,664 $ 44,275,988 $ (40,285,386) $ 7,492,266
Ending balance, shares at Jun. 30, 2022 350,000 16,646,593